Liraglutide studies: 1,219 papers with results
Page 21 of 25
- Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia.
Buturovic BA · Medical archives (Sarajevo, Bosnia and Herzegovina) · 2014
Not a test of Liraglutide alone · 7 results
- GLP-1 receptor agonist therapy before bariatric surgery: Effects on weight loss and body composition in clinical practice.
Gutiérrez-Medina S · Obesity research & clinical practice · 2026
Not a test of Liraglutide alone · 14 results
- Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials.
Chen Q · BMC endocrine disorders · 2026
Not a test of Liraglutide alone · 14 results
- Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists.
Kerr KW · Childhood obesity (Print) · 2026
Not a test of Liraglutide alone · 21 results
- Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
Amori RE · JAMA · 2007
Not a test of Liraglutide alone · 6 results
- Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF · Diabetes, obesity & metabolism · 2012
Not a test of Liraglutide alone · 6 results
- Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.
Nauck MA · Diabetes, obesity & metabolism · 2017
Not a test of Liraglutide alone · 6 results
- A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
Heller SR · Diabetologia · 2022
Not a test of Liraglutide alone · 6 results
- Real-world study on the effectiveness and safety of basal insulin IDegLira in type 2 diabetic patients previously treated with multi-injective insulin therapy.
Persano M · European review for medical and pharmacological sciences · 2021
Not a test of Liraglutide alone · 6 results
- Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.
Alexander GC · JAMA internal medicine · 2026
Not a test of Liraglutide alone · 12 results
- Evaluation of the long-term cost-effectiveness of liraglutide therapy for patients with type 2 diabetes in France.
Roussel R · Journal of medical economics · 2016
Not a test of Liraglutide alone · 6 results
- Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review.
Au HCT · Acta neuropsychiatrica · 2025
Not a test of Liraglutide alone · 12 results
- Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Wen J · Endocrinology, diabetes & metabolism · 2025
Not a test of Liraglutide alone · 18 results
- Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.
Liakopoulou P · Endocrine · 2017
Not a test of Liraglutide alone · 6 results
- Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
Home PD · Diabetes, obesity & metabolism · 2020
Not a test of Liraglutide alone · 6 results
- Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
McCrimmon RJ · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Not a test of Liraglutide alone · 9 results
- Non-Arteritic Anterior Ischemic Optic Neuropathy in an Otherwise Healthy Young Adult Patient Treated with Liraglutide and Semaglutide for Weight Loss: A Cautionary Tale.
Lixi F · International medical case reports journal · 2025
Not a test of Liraglutide alone · 11 results
- Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Philis-Tsimikas A · Journal of diabetes science and technology · 2024
Not a test of Liraglutide alone · 6 results
- The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review.
Völker KM · Frontiers in pharmacology · 2025
Not a test of Liraglutide alone · 12 results
- Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring.
Kawaguchi Y · Journal of diabetes investigation · 2024
Not a test of Liraglutide alone · 6 results
- Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.
Fujioka K · Journal of diabetes science and technology · 2015
Not a test of Liraglutide alone · 6 results
- Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy.
Utzschneider KM · Diabetes care · 2024
Not a test of Liraglutide alone · 6 results
- Effect of Medical and Surgical Interventions on α-Cell Function in Dysglycemic Youth and Adults in the RISE Study.
Kahn SE · Diabetes care · 2021
Not a test of Liraglutide alone · 6 results
- Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase-4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials.
Janez A · Diabetes, obesity & metabolism · 2020
Not a test of Liraglutide alone · 6 results
- Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A systematic review and Meta-Analysis of randomized controlled trials.
Joy B · Endocrine · 2026
Not a test of Liraglutide alone · 16 results
- Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.
Khan SA · Digestive diseases and sciences · 2026
Not a test of Liraglutide alone · 24 results
- Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
Chan TH · Diabetes, obesity & metabolism · 2026
Not a test of Liraglutide alone · 12 results
- Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial.
Gómez-Medina AM · Diabetologia · 2025
Not a test of Liraglutide alone · 6 results
- Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.
Capehorn M · Advances in therapy · 2025
Not a test of Liraglutide alone · 13 results
- Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review.
Mirghani H · Frontiers in endocrinology · 2026
Not a test of Liraglutide alone · 18 results
- Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.
Lipska KJ · Annals of internal medicine · 2026
Not a test of Liraglutide alone · 16 results
- A Novel Approach to Managing "Double Diabetes" in a Pediatric Patient on Insulin Pump Therapy: An Off-Label Use of a Fixed-Ratio Insulin Degludec/Liraglutide Combination.
Almoallem B · Cureus · 2026
Not a test of Liraglutide alone · 6 results
- A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland.
Barrett R · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2025
Not a test of Liraglutide alone · 6 results
- Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial.
Rodbard HW · Diabetic medicine : a journal of the British Diabetic Association · 2017
Not a test of Liraglutide alone · 5 results
- Sex Differences in the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta-Analysis.
Yang Y · Journal of diabetes · 2025
Not a test of Liraglutide alone · 6 results
- Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.
Ayoub M · Journal of clinical medicine · 2025
Not a test of Liraglutide alone · 15 results
- Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic Review.
Liang Y · Journal of Alzheimer's disease reports · 2024
Not a test of Liraglutide alone · 5 results
- Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
Yoshida Y · Journal of diabetes and its complications · 2022
Not a test of Liraglutide alone · 10 results
- Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
Aroda VR · The lancet. Diabetes & endocrinology · 2019
Not a test of Liraglutide alone · 5 results
- The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis.
Guo X · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2022
Not a test of Liraglutide alone · 14 results
- Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan.
Onishi Y · Endocrine journal · 2017
Not a test of Liraglutide alone · 12 results
- Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials.
Kang YM · Diabetes & metabolism journal · 2019
Not a test of Liraglutide alone · 10 results
- Effect of Glucagon-like Peptide-1 Receptor Agonists on All-cause Mortality and Cardiovascular Outcomes: A Meta-analysis.
Peterson SC · Current diabetes reviews · 2018
Not a test of Liraglutide alone · 5 results
- The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: A systematic review and meta-analysis.
Maciel MG · Diabetes research and clinical practice · 2018
Not a test of Liraglutide alone · 5 results
- Effect of glucagon-like peptide-1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta-analysis.
Duan K · Journal of diabetes investigation · 2022
Not a test of Liraglutide alone · 5 results
- Is insulin the most effective injectable antihyperglycaemic therapy?
Buse JB · Diabetes, obesity & metabolism · 2015
Not a test of Liraglutide alone · 5 results
- Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment.
Kramer CK · The Journal of clinical endocrinology and metabolism · 2024
Not a test of Liraglutide alone · 10 results
- An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin.
Evans M · Journal of medical economics · 2018
Not a test of Liraglutide alone · 5 results
- Evaluation of the long-term cost-effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.
Hunt B · Diabetes, obesity & metabolism · 2017
Not a test of Liraglutide alone · 5 results
- Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
Candler T · Journal of pediatric endocrinology & metabolism : JPEM · 2020
Not a test of Liraglutide alone · 5 results